Artedouglasia oxide C is a niche oxygenated sesquiterpene best known as an analytical marker in Cape chamomile and some Artemisia volatile profiles. Current live evidence is strong for identity, stereochemical naming, and occurrence data, but weak for isolated pharmacology, mechanism, and human safety. For AromaForge, it is most accurate to describe artedouglasia oxide C as a compositional marker constituent with clearly documented evidence gaps rather than a standalone wellness-active.
Chemical identity and composition
NIST lists artedouglasia oxide C with formula C15H22O3 and InChIKey YDGSUVJUYWCJCE-JQXSQYPDSA-N. The Good Scents entry uses the stereochemical name (2R)-2-[(5S)-5-ethenyl-5-methyloxolan-2-yl]-2,6,6-trimethylpyran-3-one and CAS 115403-98-0, while archive oil data already places it in Cape chamomile at about 2.2% typical.
Aroma and practical use
- Use the recorded cape chamomile-like, woody herbal, soft terpene descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
cape chamomile marker constituent
A Cape chamomile composition paper reported artedouglasia oxide C among named constituents, and the archive record derived from that source places it at 2.2% typical in the commercial oil profile.
Measured: constituent identification and percentage reporting
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
artemisia occurrence marker
A study snippet on Artemisia persica reported artedouglasia oxide C at 13.2% among major constituents, showing that the compound is not exclusive to Cape chamomile chemistry.
Measured: major-component listing
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedThe Good Scents entry shows no hazard statements found, but also marks the material as not for fragrance use and not for flavor use, so this should not be treated as a positive safety endorsement.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
No constituent-specific human safety trial, dermal limit monograph, or phototoxicity review for isolated artedouglasia oxide C was located in this research pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Because the accessible literature is dominated by occurrence data, practical safety framing should remain conservative and tied to parent-oil context rather than isolated-compound claims.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
no isolated mechanism verified
No primary source located in this pass established a constituent-specific molecular mechanism for isolated artedouglasia oxide C.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- No isolated artedouglasia oxide C pharmacology or mechanism paper was verified in this pass.
- Public safety evidence is sparse and does not support a numeric topical-use limit.
- Occurrence evidence is stronger than bioactivity evidence, so future upgrades should prioritize primary toxicology or isolated-compound assay papers.
- 2026-07-13 re-verification (worker c3): a targeted search for artedouglasia oxide C (CAS 115403-98-0) dermal safety data returned only identity databases (NIST, Chemsrc); no authoritative safety source located, dermal_limit_verified remains false.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.